These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 426839)

  • 1. Further studies on the dissociation of the isosafrole metabolite-cytochrome P-450 complex.
    Dickins M; Elcombe CR; Moloney SJ; Netter KJ; Bridges JW
    Biochem Pharmacol; 1979; 28(2):231-8. PubMed ID: 426839
    [No Abstract]   [Full Text] [Related]  

  • 2. Ligand binding of safrole to cytochrome P-450.
    Delaforge M; Ioannides C; Parke DV
    Arch Toxicol Suppl; 1980; 4():45-8. PubMed ID: 6933961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings: Properties of the safrole metabolite-cytochrome P-450 complex.
    Elcombe CR; Bridges JW; Netter KJ
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R72. PubMed ID: 1143487
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective reactivation of steroid hydroxylases following dissociation of the isosafrole metabolite complex with rat hepatic cytochrome P-450.
    Murray M; Zaluzny L; Farrell GC
    Arch Biochem Biophys; 1986 Dec; 251(2):471-8. PubMed ID: 3800378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substrate-elicited dissociation of a complex of cytochrome P-450 with a methylenedioxyphenyl metabolite.
    Elcombe CR; Bridges JW; Nimmo-Smith RH
    Biochem Biophys Res Commun; 1976 Aug; 71(4):915-9. PubMed ID: 971317
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of safrole and isosafrole and their metabolites with cytochromes P-450.
    Ioannides C; Delaforge M; Parke DV
    Chem Biol Interact; 1985 May; 53(3):303-11. PubMed ID: 4006010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation, purification, and properties of a unique form of cytochrome P-450 in microsomes of isosafrole-treated rats.
    Fisher GJ; Fukushima H; Gaylor JL
    J Biol Chem; 1981 May; 256(9):4388-94. PubMed ID: 6783662
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between the metabolism and toxicity of benzodioxole compounds.
    Bridges JW; Fennell TR
    Adv Exp Med Biol; 1981; 136 Pt B():881-93. PubMed ID: 7344519
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro formation of an inhibitory complex between an isosafrole metabolite and rat hepatic cytochrome P-450 PB-B.
    Murray M; Reidy GF
    Drug Metab Dispos; 1989; 17(4):449-54. PubMed ID: 2571488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-complex formation between cytochromes P-450 and P-448 and methylenedioxyphenyl compounds.
    Delaforge M; Ioannides C; Parke DV
    Xenobiotica; 1985 Apr; 15(4):333-42. PubMed ID: 4024668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic microsomal cytochrome P-450 from rats treated with isosafrole. Purification and characterization of four enzymic forms.
    Ryan DE; Thomas PE; Levin W
    J Biol Chem; 1980 Aug; 255(16):7941-55. PubMed ID: 6772643
    [No Abstract]   [Full Text] [Related]  

  • 12. Selective inhibition of the safrole-induced mixed-function oxidase activities by 9-hydroxyellipticine.
    Delaforge M; Ioannides C; Parke DV
    Chem Biol Interact; 1982 Dec; 42(3):279-89. PubMed ID: 7151231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The side-chain epoxidation and hydroxylation of the hepatocarcinogens safrole and estragole and some related compounds by rat and mouse liver microsomes.
    Swanson AB; Miller EC; Miller JA
    Biochim Biophys Acta; 1981 Apr; 673(4):504-16. PubMed ID: 7225430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safrole: its metabolism, carcinogenicity and interactions with cytochrome P-450.
    Ioannides C; Delaforge M; Parke DV
    Food Cosmet Toxicol; 1981 Oct; 19(5):657-66. PubMed ID: 7030889
    [No Abstract]   [Full Text] [Related]  

  • 15. Piperonyl butoxide metabolism by cytochrome P-450: factors affecting the formation and disappearance of the metabolite-cytochrome P-450 complex.
    Franklin MR
    Xenobiotica; 1972 Nov; 2(6):517-27. PubMed ID: 4145693
    [No Abstract]   [Full Text] [Related]  

  • 16. The characterization of an inhibitory complex formed with cytochrome P-450 and a metabolite of 1,1-disubstituted hydrazines.
    Hines RN; Prough RA
    J Pharmacol Exp Ther; 1980 Jul; 214(1):80-6. PubMed ID: 7391974
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of cytochrome P-450c-mediated benzo[a]pyrene hydroxylase and ethoxyresorufin O-deethylase by dihydrosafrole.
    Kao LR; Wilkinson CF
    Xenobiotica; 1987 Jul; 17(7):793-805. PubMed ID: 3660849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enzymic formation of methylenedioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes.
    Franklin MR
    Xenobiotica; 1971 Nov; 1(6):581-91. PubMed ID: 4154538
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of isosafrole and dihydrosafrole in the rat.
    Klungsøyr J; Scheline RR
    Biomed Mass Spectrom; 1982 Aug; 9(8):323-9. PubMed ID: 7126764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of rat hepatic microsomal cytochrome P-450 by 2,3',4,4',5,5'-hexachlorobiphenyl.
    Parkinson A; Robertson LW; Safe SH
    Biochem Pharmacol; 1983 Jul; 32(14):2269-79. PubMed ID: 6409119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.